Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prostate Cancer Malignancy Grading Using Prostate Specific Membrane Antigen (PSMA) PET and Machine Learning

NCT07266129 is registered in ClinicalTrials.gov with University Hospital of North Norway as lead sponsor.

NCT NCT07266129
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07266129 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prostate Cancer Malignancy Grading Using Prostate Specific Membrane Antigen (PSMA) PET and Machine Learning
Lead sponsor
University Hospital of North Norway
Phase
Observational
Overall status
Recruiting
Start date
June 3, 2024
Completion date
December 31, 2027
Enrollment
220 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer (diagnosis)